Last reviewed · How we verify

NCT06037382

Using a Smartphone App to Target Current Mental Health Symptoms of Anxiety and Depression

Completed NA Last updated 13 March 2025
What this trial tests

NA trial testing Mood Triggers App in Depression in 102 participants. Completed in 6 March 2025.

Timeline
25 September 2023
Primary endpoint
6 March 2025
6 March 2025

Quick facts

Lead sponsorTrustees of Dartmouth College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment102
Start date25 September 2023
Primary completion6 March 2025
Estimated completion6 March 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Trustees of Dartmouth College

Who can join

Adults 40 to 64, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prevention intervention study that will examine the efficacy of a smartphone-based intervention in decreasing cancer risk by targeting mental health risk factors of anxiety and depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Trustees of Dartmouth College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06037382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing